Total Return chart Shield Therapeutics plc

Stocks

Delayed London S.E. 05:42:16 2026-09-01 EDT			5-day change	1st Jan Change
6.300 ^GBX	+3.28%		+34.04%	-36.04%

08-28	WINNERS & LOSERS: McBride rises on deal win; Watkin Jones slumps	AN
08-28	Shield Therapeutics to Take Over US Commercialization of ACCRUFeR	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.